Five‐year survival impact of adjuvant anti‐ PD ‐1 therapy in a nationwide cohort of stage III melanoma - Marie B. Weitemeyer; Neel M. Helvind; Shawez Khan; Pernille Bidstrup; Karina D. Steffensen; Adam Andrzej Luczak; Lars Bastholt; Henrik Schmidt; Inge Marie Svane; Marco Donia; Lisbet R. Hölmich; Eva Ellebaek (Journal of the European Academy of Dermatology and Venereology, 2026)